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Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Latin America. It is caused by the
dimorphic fungus Paracoccidioides brasiliensis. The immunodiffusion (ID) test is one of the most widely used
techniques for PCM serologic diagnosis due to the simplicity and low costs of its execution. However, it requires
trained and qualified people to execute it. The purpose of this study was to evaluate a latex particle aggluti-
nation (LA) test for the detection of anti-P. brasiliensis antibodies by using pooled crude exoantigens from the
fungus. Fifty-one serum samples obtained from patients with PCM were tested. Positivity was observed in 84%
(43/51) of these patients, and the agglutination patterns varied from small clumps with a cloudy background
to large clumps with a clear background. The antibody titer reactivity ranged from 1:2 to 1:64. Cross-reactivity
was observed in sera from patients with aspergillosis, histoplasmosis, and nonfungal disease. Serum samples
obtained from healthy donors were not reactive. The sensitivity and specificity of the LA test were 84% and 81%,
respectively. When comparing the LA test with the double-immunodiffusion test, we found an agreement of
92%. Further work is needed to improve the performance of the LA assay before it can be proposed as a reliable
diagnostic tool, mainly in laboratories with little infrastructure.
Paracoccidioides brasiliensis is the etiologic agent of paracoc-
cidioidomycosis (PCM), a thermally dimorphic fungus that
grows in a mycelial form at room temperature and in a budding
yeast form at 35 to 37°C in host tissue or when cultured at 37°C
(3). The disease is limited to Latin American countries, and the
most important regions of endemicity are found in Brazil,
Colombia, and Venezuela (14). In Brazil, PCM is considered
the eighth most common cause of death among infectious and
parasitic chronic diseases, surpassing leishmaniasis, with a
mortality rate of 1.45 per million population (4).
Conidia of P. brasiliensis act as infectious propagules which
are inhaled into the lungs, where transformation to the patho-
genic yeast form occurs (10). PCM exhibits a wide spectrum of
clinical and pathological manifestations, ranging from benign
and localized forms to severe disseminated disease (11). In
most cases, the infection is restricted primarily to the lungs but
can spread to other organs (16). The disease presents two
major clinical forms: (i) the acute or subacute form (juvenile
type), with severe involvement of the mononuclear phagocyte
system, and (ii) the chronic form (adult type), with slow evo-
lution and involvement of one or more organs, usually the
lungs (7).
The definitive diagnosis of PCM is usually made by visual-
ization or isolation of the fungus from the lesions. Serologic
tests appear to offer a means to achieve an early diagnosis of
the disease (1, 5). Detection of antibodies in serum has been
one of the main tools for the diagnosis of PCM and may be
useful to monitor its evolution and its response to treatment.
Among the different serologic techniques, the double-immu-
nodiffusion (ID) test is the most commonly used and presents
sensitivity values that vary from 80 to 95% (12). However, this
technique is feasible only in reference laboratories due to the
necessity of having special reagents and experienced people to
conduct the test. The development of a simpler and less ex-
pensive methodology is greatly needed by laboratories with
little infrastructure, especially in poor countries with areas
where the disease is endemic. Such a test could contribute to
the diagnosis and the screening of PCM, mainly in hospital and
public health laboratories, and thereby expand diagnoses of
this infection, which affects individuals in their most productive
period of life, especially male adults who live in rural areas.
Investigators have shown the latex particle agglutination
(LA) test to be a valuable tool for the diagnosis of various
diseases, including fungal infections (9, 15). In 1978, Restrepo
and Moncada (15), using an LA test with a crude exoantigen
prepared from a pool of three strains of P. brasiliensis (B 339,
B 341, C 81) for the detection of antibodies, showed that the
maximum sensitivity value of the assay was 69.5%, while the
specificity value varied from 18.5% to 46.8%.
In order to improve the serological parameters of the agglu-
tination method for the diagnosis of PCM, the present study
had the objectives of producing a rapid LA test using pooled
crude exoantigen of P. brasiliensis and evaluating its possible
use in the serological diagnosis of this mycosis, as well as of
comparing results with those of the ID test, which has already
been established as a diagnostic tool for PCM.
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MATERIALS AND METHODS
Sera and patients. Fifty-one serum samples obtained from patients with active
PCM (47 males and 4 females ranging from 15 to 75 years of age) were included
in the study. Six patients presented with the acute form and 45 patients the
chronic form of the disease. All of them exhibited clinical and laboratory signs of
the disease, such as central nervous and pulmonary system involvement, mucosal
or mucocutaneous lesions, and increased specific-antibody levels. The diagnosis
was confirmed either by direct examination of biological fluids (n  4), by
serological immunodiffusion tests (n  25), or by both tests (n  22). Eleven
serum samples from patients with histoplasmosis (HP), 15 from patients with
aspergillosis (ASP), and 49 from patients with nonfungal disease (patients pre-
senting bacterial infections) were used. On the other hand, 20 serum specimens
from healthy individuals with no history of pulmonary disease were also studied.
These sera were termed normal human sera (NHS) and were individually tested
and used as negative controls. All serum specimens were divided into aliquots
and were stored at 20°C.
Fungal strains and crude exoantigen production. Three isolates of P. brasil-
iensis (Pb34, Pb113, and PbIOC), obtained from the culture collection of
Evandro Chagas Institute, were selected for this study. The isolates were initially
grown on Sabouraud medium slant tubes for 3 days at 35°C. The growth (con-
sisting entirely of yeast cells) was collected from at least 10 tubes, yielding an
inoculum of approximately 2 106 cells. These cells were inoculated into 500-ml
Erlenmeyer flasks containing 100 ml of yeast extract-peptone-dextrose (YEPD)
broth (Difco, Sparks, MD). This culture was incubated for 3 days at 35°C on a
gyratory shaker at 50 rpm (Fanem, Sa˜o Paulo, Brazil). The growth obtained was
transferred to 1,800-ml Fernbach flasks containing 500 ml of YEPD broth. The
flasks were then incubated as described above for 7 more days. The culture was
killed with thimerosal (0.2 g/liter). Supernatant fluids were collected following
paper filtration, concentrated under vacuum at 45°C, and dialyzed against dis-
tilled water. After dialysis, the solution was concentrated again (6).
The protein content was measured by the Bradford method (2), and the
electrophoretic pattern was analyzed by SDS-PAGE (8), followed by silver ni-
trate staining.
ID test. Immunodiffusion was performed with pooled crude exoantigen of P.
brasiliensis as described previously (5). Each PCM, HP, ASP, and NHS specimen
was individually tested against an antigenic preparation from P. brasiliensis
strains (Pb34, Pb113, and PbIOC), and the titer of each serum sample was
determined.
Preparation of the LA test. The LA test antigen consisted of a pool of six lots
of crude exoantigen adjusted to a concentration of 400 g/ml and was used to
coat the test latex particles. A 1% suspension of latex polystyrene beads (diam-
eter, 0.8 m; Sigma, St. Louis, MO) in carbonate-bicarbonate-buffered saline
solution (pH 9.2) was sensitized by mixing the beads with pooled crude exoan-
tigen of P. brasiliensis at 4°C overnight before the addition of bovine serum
albumin (BSA) to a final concentration of 0.1% (wt/vol). The optimal solution
for use was the one that produced a clear agglutination with the sera of exper-
imentally infected animals and with positive-control sera from patients with
PCM. The latex particles (1% suspension) were coated primarily with pooled
crude exoantigen (400 g/ml). The LA test was performed by placing 25 l of the
latex suspension on a dark slide. A total of 25 l of serum was added to the latex
particles. After the reagents were mixed, the slide was gently agitated in a Kline
agitator for 5 min. Negative-control latex consisted of 25 l of latex solution
added to 25 l of saline solution. Samples were considered positive for P.
brasiliensis antibodies when agglutination (clumping) was observed. The grading
of agglutination was defined as negative when the suspension had a fine granular
background or a milky aspect with the absence of agglutination, a one plus (1)
suspension had small clumping against a cloudy background, a two plus (2)
suspension had small to moderately sized clumps against a slightly cloudy back-
ground, a three plus (3) suspension presented moderately sized and large
clumps against a clear background, and a four plus (4) suspension had large
clumps with a very clear background. After the screening test of the undiluted
serum samples, if the agglutination grade was 1 or higher, the reaction mixtures
were titrated (1:2 through 1:1,024).
Statistical analysis. Receiver operating characteristic (ROC) curve analysis
was performed to determine the cutoff for positivity that would give the optimal
sensitivity and specificity. Agreement was calculated by the following formula:
(A  D)/(A  B  C  D), where A is a specimen with positive results by both
LA and ID, B is a specimen with a positive result by LA but a negative result by
ID, C is a specimen with a negative result by LA but a positive result by ID, and
D is a specimen with negative results by both assays.
RESULTS
Immunodiffusion and SDS-PAGE analysis of pooled crude
exoantigen. As shown by the immunodiffusion (ID) test, the P.
brasiliensis pooled crude exoantigen reacted positively up to
the dilution 1:16. SDS-PAGE exoantigen showed at least 12
components (15 to 180 kDa) following silver staining. The
main P. brasiliensis antigenic determinants gp43 and gp70 were
observed.
Detection of antibodies by the ID and LA tests. Serum spec-
imens from 51 cases of PCM and 95 controls, including 26
cases with fungal infection (HP, ASP), 20 cases of NHS, and 49
cases of nonfungal diseases were tested simultaneously by ID
and LA using a pooled crude exoantigen (Table 1). Among
these 51 PCM sera, 47 (92%) were positive and 4 (8%) were
not reactive by the ID test. The serum titers obtained by the ID
test ranged from 1:2 to 1:1,024 (Table 2). Five PCM sera
reacted only with nondiluted serum. ROC analysis identified
the optimal cutoff for positivity to be the agglutination pattern
equivalent to one plus (1). The sensitivity and specificity of
the ID test were 92% and 100%, respectively. The LA test
sensitivity was 84%, the specificity was 81%, and the area
under the curve was 0.841 (Fig. 1). The LA and ID tests
presented an agreement of 92%.
In the LA test, the cutoff value was determined to be one
TABLE 1. Detection by the ID and LA tests of anti-P. brasiliensis
antibodies in sera from patients with PCM or other mycoses
and in sera from healthy individuals
Patient group
No. of
specimens
with ID
test result:
Total
no. of
specimens
No. of
specimens
with LA
test result:
Total
no. of
specimens
Positive Negative Positive Negative
PCM
Acute 6 0 6 6 0 6
Chronic 41 4 45 37 8 45
Unifocal 19 3 22 17 5 22
Multifocal 22 1 23 20 3 23
Histoplasmosis 0 11 11 3 8 11
Aspergillosis 0 15 15 4 11 15
Nonfungal diseases 0 49 49 11 38 49
NHSa 0 20 20 0 20 20
a 2  42,759; P  0.0001, PCM and NHS.
TABLE 2. Reactivities of 51 PCM patient serum samples
by the ID and LA tests
Serum
ID LA
No. of
specimens % positive
No. of
specimens % positive
Not diluted 5 10 16 32
1:2 10 19 5 10
1:4 13 25 3 6
1:8 7 14 5 10
1:16 4 8 4 8
1:32 2 4 8 15
1:64 4 8 2 4
1:64a 2 4 0 0
Nonreactive 4 8 8 15
Total 51 100 51 100
a One sample corresponded to a dilution of 1:128 and other to 1:1,024.
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plus (1) and anti-P. brasiliensis antibodies were detected in 43
out of 51 (84%) serum samples; false-negative results were
observed in 8 (16%) samples. Figure 2 shows the results ob-
tained when patients’ sera were classified according to the
screening results and to the titration procedures. Figure 2A
shows the results ranging from 1 to 4 for nondiluted sera.
Figure 2B shows antibody titers ranging from 1:2 to 1:64 after
titration.
The ID and LA tests were able to detect anti-P. brasilien-
sis antibodies in the acute-PCM form. Of the sera collected
from patients with the chronic form, four presented negative
results (1 chronic multifocal form, 3 chronic unifocal forms),
whereas in the LA test, eight serum samples presented neg-
ative results (3 chronic multifocal forms, 5 chronic unifocal
forms) (Table 1).
In the ID test, serum samples from patients with the acute
form of PCM showed antibody titers ranging from 1:4 to
1:1,024. On the other hand, in the LA test, antibody levels
ranged from 1:8 to 1:32. Considering the chronic form, anti-
body titers varied from 1:2 to 1:128 by the ID test and from 1:2
FIG. 1. ROC curve depicting assay sensitivity and specificity based upon testing sera from 51 patients with PCM and 95 controls, including
patients with histoplasmosis, aspergillosis, and nonfungal diseases and healthy subjects. With a cutoff of one plus (1), the sensitivity is 84% and
the specificity is 81%.
FIG. 2. Detection of anti-P. brasiliensis antibodies by the LA test in the sera of 51 patients with PCM and 95 controls, including patients with
histoplasmosis (HP), aspergillosis (ASP), and nonfungal diseases (bacterial infection [BI]) and healthy subjects (NHS). (A) Screening test of the
undiluted sera. (B) The titer is reported as the highest dilution showing a 2 or greater reaction. P, nondiluted sera; N, negative. The long, fine
line represents the cutoff point (1).
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to 1:64 by the LA test. Figure 3 shows the results obtained
when patients’ sera were separated according to the different
clinical forms. Four sera negative by the ID test were also
negative by the LA test. The antibody titers observed in the ID
test were higher than those observed in the LA test (Fig. 3).
A total of 95 heterologous serum samples were tested by the
ID and LA tests, including samples from patients with histo-
plasmosis (n 11), patients with aspergillosis (n 15), healthy
donors (n  20), and patients with nonfungal disease (n  49).
In the ID test, all non-PCM serum samples were negative.
However, in the LA test, cross-reactivity was obtained with
sera from patients with histoplasmosis (27%; 3/11), aspergillo-
sis (27%; 4/15), and nonfungal disease (22%; 11/49). None of
these samples reacted at a titer higher than 1:4. No positive
reaction was observed in the sera of healthy donors (Table 1;
Fig. 2A and B). There were statistically significant differences
when the positive reactions of the LA test serum samples from
patients with PCM were compared with those of NHS samples
(P  0.0001) (Table 1), which indicates that the test is able to
discriminate patients with the disease from those without the
disease.
DISCUSSION
Serological tests are useful tools for the diagnosis of systemic
fungal infections. These tests are based either on the detection
of serum antibodies against fungal components or on the de-
tection of products of the fungus itself. Their effectiveness
depends on the reagents, the antigenic preparation, the meth-
ods used, and also on a comprehension of their limitations and
a precise interpretation of the results obtained. However, they
are not routinely available in most public health services. Only
a few research laboratories located in areas where systemic
mycosis is considered endemic perform them. Paracoccidioido-
mycosis is endemic in Brazil; however, it is not a notifiable
disease, and its real prevalence and incidence cannot be cal-
culated, which makes it difficult to establish its impact on the
different Brazilian states.
Our study evaluated the development of a serologic test
using latex particles coated with pooled crude exoantigen of P.
brasiliensis. P. brasiliensis is a fungus that grows appropriately
in a variety of different media, and we obtained a very good
antigenic preparation from yeast filtrate culture grown in
YEPD medium broth. This antigenic preparation has demon-
strated a high degree of sensitivity, specificity, and reproduc-
ibility in the serodiagnosis of paracoccidioidomycosis by im-
munodiffusion in our laboratory. The pooled crude exoantigen
used was obtained after homogenization of equivalent
amounts of each lot of antigen, with molecular masses ranging
from 15 to 180 kDa.
The sensitivity observed in the LA test was 84.31% (43/51),
and the antibody titer ranged from 1:2 to 1:64. Eight patients
presented false-negative results in the LA test, while in the ID
test only four serum samples were not reactive. This may be
attributed to several factors, such as different immune re-
sponses by the host, since these results were found only in sera
from patients presenting the chronic form of PCM, in which
low antibody production in PCM unifocal forms is usually
observed (12). On the other hand, it is also possible that the
fungus strain infecting these patients had different levels of
virulence, which could have influenced the immune response.
Another possibility may be the loss of conformational epitopes
in the LA test using the pooled crude exoantigen of P. brasil-
iensis.
Restrepo and Moncada (15) tested four different crude an-
tigenic preparations for PCM diagnosis by LA (mycelial and
yeast phases, both treated and not treated with ethanol). The
crude yeast filtrate used to sensitize the particles was found to
be better than the ethanol-treated yeast filtrate; however, sen-
sitivity reached only 69.5% in the assay. A cause for the dif-
ference observed between our study and that of Restrepo and
Moncada (15) concerning the sensitivity results can be ex-
plained by the chemical nature of the substances present in
yeast-phase culture filtrates, which are largely constituted of
sugars, such as glucose, galactose, arabinose, and glucosamine
(17). This antigenic preparation was employed by Restrepo
and Moncada in 1978 (15); however, its composition has lower
concentrations of antigenic proteins of interest, and it fre-
quently produces high cross-reactivity with sera of patients
with histoplasmosis and aspergillosis, influencing the specificity
of the test. We utilized an antigen standardized by de Camargo
et al. (6), whose specificity was 81.1%, whereas the assay of
Restrepo and Moncada (15) showed a maximum specificity of
46.8% when tested with sera of patients with histoplasmosis.
In our study, detection of antibodies by the ID test reached
a sensitivity of 92.16% (47/51), with antibody titers ranging
from 1:2 to 1:1,024. However, in the sera of four PCM patients,
precipitating antibodies were not detected. A possible reason
for these false-negative results may be the presence of low-
avidity IgG2 antibodies directed against carbohydrate
epitopes, which may interfere with ID tests in PCM patients
(13).
Antibody reactivity observed in both the ID and LA tests
was higher in PCM patients presenting the acute form of the
disease than in those with the chronic form. It is known that
the acute form of PCM is generally more severe, resulting in
higher titers of antibodies, than its chronic form, with which
low antibody titers or, occasionally, titer fluctuation may be
detected (12). The lack of reactivity (negative- and low-agglu-
FIG. 3. Comparative antibody titers obtained by the ID and LA
tests, grouped by PCM clinical form. ID, immunodiffusion; LA, latex
agglutination; P, nondiluted sera; N, negative.
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tination patterns [1]) in the LA tests of sera from patients
with proven PCM may be related to the production of low
titers of antibodies or to intrinsic characteristics of the patient
or the infective strain. Although cross-reactions with serum
samples from patients with other mycoses could be observed in
this test (aspergillosis [4/15] and histoplasmosis [2/11]), reac-
tivities were less intense and occurred at titers (1:4) lower than
those of sera from PCM patients and could be minimized by
progressive dilutions of the specimens. We believe that this
cross-reactivity will not hinder the use of this diagnostic tool in
the detection of antibodies for PCM. On the other hand, the
fungus probably shares common antigenic determinants or
similar determinants of related chemical structures, which
could explain cross-reaction. Travassos et al. (18) reported
that, in general, specific reactions are obtained when antigen is
in a solution similar to that in the ID test and that fixing
antigen onto a solid-phase substrate increases the number of
nonspecific reactions. Nevertheless, other assays using latex
particles coated with pooled crude exoantigens pretreated with
sodium metaperiodate (13) and serum samples pretreated with
2-	-mercaptoethanol must be conducted to eliminate cross-
reactivity. Such a procedure will optimize the chances of
accurately identifying true-positive LA test results in serum
samples.
One of the main problems in the serodiagnosis of PCM
based on antibody detection is the cross-reaction obtained with
sera from patients with other mycoses, mainly histoplasmosis
and aspergillosis (12, 15). On the other hand, lack of reactivity
or low antibody titers have been a very common problem in our
region. With the cutoff set at 1 and the subsequent titration
of the samples, some patients with proven PCM were serolog-
ically classified as negative by the LA test. However, some of
these patients also had negative results by the ID test. We
believe that the format of the test and the patient’s immune
status may have contributed to such results. However, it is
possible that other factors (prozone, the presence of rheuma-
toid factor, and other serum macroglobulins) interfere with the
performance of the test, which means that new studies must be
conducted in order to better evaluate this serological pattern.
The ID test is still the gold standard serological test used in
the diagnosis of PCM. It shows sensitivity and specificity of
approximately 95 to 100% (5, 13). It is an easy-to-perform
simple test whose results can be obtained within 4 days; it is
used mainly in research institutes, because it requires equip-
ment and qualified laboratory staff for the production of anti-
gens. These antigens show great variability, making it very
difficult to standardize the diagnostic techniques in different
laboratories.
The LA test used for other fungal pathologies has the ad-
vantage of being rapid and simple, and it is not affected by
anticomplement activity (9). Another important advantage of
this test is its stability. Sensitized latex beads were found to be
able to retain similar agglutination sensitivities after storage at
4°C for at least 4 months (data not shown). By following the
precise procedure in the test, the assay can be useful as a
screening test in hospitals and public health laboratories,
where the use of a battery of tests or more complex procedures
is not feasible. The rapid agglutination-based latex particle
assay developed in this study showed that it is crucial to exam-
ine the effect of pretreatment of antigen and serum samples on
the performance of the assay to increase sensitivity and spec-
ificity and to minimize or eliminate cross-reactivity with sera of
patients with other mycoses before the assay can be suggested
as an additional reliable diagnostic tool in the qualitative pre-
sumptive diagnosis of PCM and for use in follow-up studies in
areas where the disease is endemic, mainly in laboratories with
poor infrastructure.
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